GlassScriptPhysician profile
Eugene Blanchard Cone
NPI 1083955538
$114,264.67
in general payments reported to CMS, 2019-2025
41 companies · $57K in 2025
The $57K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,703 · 2023: $10K · 2024: $45K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Consulting Fee: $28K · Long Term Medical Supply Or Device Loan: $22K · Food and Beverage: $8,966 · Travel and Lodging: $7,963 · Honoraria: $2,113 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,690.00 |
| Consulting Fee | $27,724.25 |
| Long Term Medical Supply Or Device Loan | $22,071.43 |
| Food and Beverage | $8,965.95 |
| Travel and Lodging | $7,962.91 |
| Honoraria | $2,112.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28,543.56 | 2022-2025 | Keytruda |
| Central Indiana Urs Consumables, LLC | $22,071.43 | 2024-2025 | Dornier Medtech, Cvac Aspiration System, Dornier Medtech |
| Janssen Biotech, INC. | $21,864.75 | 2022-2025 | Rybrevant, Carvykti, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $11,577.40 | 2022-2024 | |
| Pfizer INC. | $9,793.44 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $5,683.85 | 2022-2025 | Erleada, Akeega |
| Immunitybio, INC. | $3,476.92 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,819.09 | 2023-2025 | Imfinzi, Lynparza |
| Urogen Pharma, INC. | $2,253.26 | 2023-2025 | Jelmyto |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Dendreon Pharmaceuticals LLC | $900.88 | 2023-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $669.99 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $667.31 | 2023-2025 | Adstiladrin |
| Histosonics, INC. | $491.41 | 2025 | |
| Agiliti Surgical, INC. | $425.40 | 2023-2024 | Sonablate, Sonablate Hifu, Endocare Cryocare Cs System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $317.52 | 2022-2023 | |
| Astellas Pharma US INC | $224.17 | 2023-2024 | Xtandi |
| Progenics Pharmaceuticals, INC. | $172.25 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $151.03 | 2023-2025 | Gemtesa, Orgovyx |
| Telix Pharmaceuticals | $130.50 | 2024-2025 | Illuccix |
| Bioprotect Medical, INC. | $118.73 | 2025 | Bioprotect Balloon Implant System |
| Tolmar, INC. | $105.37 | 2023-2025 | Eligard, Jatenzo |
| Accord Healthcare, INC. | $103.93 | 2024-2025 | |
| Intuitive Surgical, INC. | $98.86 | 2022 | |
| Tempus Ai, INC | $92.41 | 2024 | |
| Procept Biorobotics Corporation | $82.56 | 2024 | Aquabeam System |
| Abbvie INC. | $64.55 | 2023-2025 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $55.29 | 2023-2025 | Prolaris |
| Edap Technomed INC | $45.00 | 2024 | |
| Sun Pharmaceutical Industries INC. | $39.61 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $38.62 | 2025 | Bard Urinary Drainage Bag |
| Civco Medical Instruments | $28.67 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $25.92 | 2024 | |
| Urovant Sciences INC | $22.89 | 2022 | |
| Becton, Dickinson and Company | $22.53 | 2023 | Bard Urinary Drainage Bag |
| Davol INC. | $19.90 | 2022 | |
| Angiodynamics, INC. | $17.67 | 2025 | Nanoknife |
| Bayer Healthcare LLC | $17.27 | 2025 | |
| Cook Medical LLC | $16.03 | 2023 | Tornado |
| Sanara Medtech INC. | $14.70 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,040.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Cone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.